RWA
TEVA icon

Redhawk Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Redhawk Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.02M Buy
+51,041
New +$1.82M 0.2% 109
2025
Q1 		– Sell
-52,416
Closed -$1.16M – 326
2024
Q4 		$1.16M Buy
+52,416
New +$954K 0.16% 112

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
CA
Continental Advisors Park City, Utah $233M AUM 14.5% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.2B AUM 15.74% 1-Year Est. Return
VSQM
V-Square Quantitative Management Chicago, Illinois $1.09B AUM 23.97% 1-Year Est. Return

Redhawk Wealth Advisors's TEVA Position: Q3 2026 in Review

Redhawk Wealth Advisors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 51,041 shares worth $2.02M. The stake represents 0.2% of the portfolio and ranks #109 among its holdings. This is a return to the name: Redhawk Wealth Advisors previously reported a position in TEVA as recently as Q4 2024.

Redhawk Wealth Advisors first reported a position in TEVA in Q4 2024 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Redhawk Wealth Advisors held 51,041 shares of Teva Pharmaceutical Industries Limited worth $2.02M as of Q3 2026.
  • Teva Pharmaceutical Industries Limited was a new Redhawk Wealth Advisors position in Q3 2026.
  • Teva Pharmaceutical Industries Limited made up 0.2% of Redhawk Wealth Advisors's portfolio in Q3 2026, its #109 holding.
  • Redhawk Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2024 and has held it in 2 quarters since.
  • 39 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.